The a16z board-seat probe is a governance lesson, not gossip

The a16z DOJ investigation into board seats is being read as Silicon Valley palace intrigue, and I think that's the wrong frame. TechCrunch's Equity podcast covered it in Will the DOJ's investigation into a16z spook other VCs?, and the useful part isn't who is in trouble.

It's the question underneath: a board seat is a legal position with information attached. Most small teams I know hand them out like thank-you notes.

---

🔍 What is actually being investigated

Per the episode, the Department of Justice has been looking at Andreessen Horowitz for close to a year, following a Bloomberg report on 17 August 2026. The specific concern is a16z people sitting on the boards of AI companies that overlap or compete.

Two seats came up by name:

Person	Board seat named in the episode
Ben Horowitz	Databricks
Martin Casado (a16z partner)	Fivetran

The hosts — Kirsten Korosec, Sean O'Kane and Anthony Ha — spent more time on the why now than the legal merits. Korosec's line was blunt:

"Of all the things that the DOJ would focus on in terms of level of importance, why does this one rise to the top?"

One honest caveat: the episode does not name a statute, so I'm not going to name one either. I've seen commentary confidently cite specific antitrust sections; that isn't in the source, and inventing a legal hook is how bad analysis starts.

---

📊 A board seat is not the same as an advisor title

Here's where this becomes practical for anyone building from Colombo, Galle or a bedroom in Kandy. When someone writes you a cheque and says "I'd like a seat," there are at least four different things they could mean, and they carry very different power.

Arrangement	Voting power	Sees board pack / financials	Can block a decision	Typical ask
Board director	Yes	Yes, everything	Often, via reserved matters	Lead investor
Board observer	No	Yes, usually everything	No	Follow-on investor
Information rights only	No	Periodic reports only	No	Small angel
Advisor	No	Whatever you choose to share	No	Anyone, honestly

Key takeaway: The gap between "observer" and "director" is not a formality. An observer sees your numbers and your strategy but cannot stop you. A director sees the same material and has a vote. If you don't know which one you signed, you signed the wrong one.

The a16z story is a very large version of a very small problem: the same person can end up holding the information rights of two companies that are chasing the same customers.

---

⚠️ The conflict nobody writes down

In a Sri Lankan context, the investor with two seats is rarely a mega-fund. It's a local businessperson who backed you and also backed a team doing something adjacent. Or a diaspora angel with five cheques out in the same vertical. Nobody has bad intent, and there's no paperwork describing what happens when the interests diverge.

Ask three questions before the money lands:

1. What else in this space have you funded? Not a trap — you want the list, in writing, in the email thread.
2. What are you contractually allowed to share with your other portfolio companies? Most standard investment agreements say less about this than founders assume.
3. What happens to your seat if you later invest in a direct competitor? The answer should be a written recusal or resignation clause, not a handshake.

If those feel awkward to ask, remember what the alternative looks like: your pricing model, your churn numbers and your hiring plan sitting in a board pack that a competitor's investor reads on a Sunday.

---

💰 What happens if VCs actually get cautious

The episode's real question is whether large funds start avoiding board seats altogether. Sean O'Kane's framing was that the big firms "set the example that then those smaller firms would follow."

If that's the direction, here's what I'd expect to trickle down to smaller markets over the next few years:

• More observer seats, fewer director seats. Cheaper for the fund legally, and it quietly increases founder control of the vote.
• Broader information rights as compensation. They give up the vote, they ask for more reporting. Read that clause.
• Longer diligence on your existing cap table. If a fund is nervous about overlaps, they'll want to know who else is already sitting at your table.
• More "no competing investments" language flowing both directions.

None of this is Sri Lankan law. Our companies are governed by the Companies Act and whatever your articles say, and the DOJ has no jurisdiction over a private limited company registered in Colombo. But if you raise from a US or Singapore fund, or go through an accelerator with US paper, you inherit their template — and their templates move when their lawyers get nervous.

---

🚀 What this means for you

If you're pre-revenue and bootstrapping, this is background reading. Bookmark it for the day it isn't.

If you're actually raising, three concrete things this week:

• Write down your current cap table and every information right attached to it. A spreadsheet is fine. Most founders I ask cannot produce this in under an hour, which is itself the finding.
• Get the company structure right before the money, not after. If you haven't incorporated yet, our Sri Lanka company registration fee calculator will tell you what the Registrar of Companies process actually costs, so cost isn't the reason you delay.
• Read the board composition clause in any term sheet twice. It's usually two sentences and it decides who controls your company at the moment things get hard.

Bottom line: The DOJ may or may not find anything at a16z. The reason to care is that it forces a question every founder should already have answered — who is in the room when your numbers are discussed, and what else are they in the room for?

Governance is the least glamorous part of building a company and the only part that's expensive to fix retroactively. A regulator is currently making that point on a very large stage. Take the free lesson.